Khawar et al., 2021 - Google Patents

Tumor spheroid-based microtumor models for preclinical evaluation of anticancer nanomedicines

Khawar et al., 2021

View PDF
Document ID
15806653795557721625
Author
Khawar I
Ghosh T
Park J
Kuh H
Publication year
Publication venue
Journal of Pharmaceutical Investigation

External Links

Snippet

Abstract Background Cancer nanomedicines (NMs) have emerged as potential anticancer therapeutics with advantages of tumor-targeting drug delivery for improved efficacy against human solid tumors. Despite promising data obtained in preclinical studies, few clinical trials …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/76—Agarose, agar-agar

Similar Documents

Publication Publication Date Title
Mehta et al. Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy
Rodrigues et al. Organ‐on‐a‐chip: A preclinical microfluidic platform for the progress of nanomedicine
Pinto et al. Three-dimensional spheroids as in vitro preclinical models for cancer research
Han et al. Challenges of applying multicellular tumor spheroids in preclinical phase
Białkowska et al. Spheroids as a type of three-dimensional cell cultures—examples of methods of preparation and the most important application
Lee et al. Generation of uniform-sized multicellular tumor spheroids using hydrogel microwells for advanced drug screening
Zanoni et al. Anticancer drug discovery using multicellular tumor spheroid models
Bhise et al. Organ-on-a-chip platforms for studying drug delivery systems
Sun et al. Microfluidic formation of coculture tumor spheroids with stromal cells as a novel 3D tumor model for drug testing
Carvalho et al. Evaluating biomaterial-and microfluidic-based 3D tumor models
Khawar et al. Tumor spheroid-based microtumor models for preclinical evaluation of anticancer nanomedicines
Picollet-D’Hahan et al. A 3D toolbox to enhance physiological relevance of human tissue models
Patel et al. Cancer cell spheroids for screening of chemotherapeutics and drug-delivery systems
Zhuang et al. Using spheroids as building blocks towards 3D bioprinting of tumor microenvironment
Kang et al. Concave microwell array-mediated three-dimensional tumor model for screening anticancer drug-loaded nanoparticles
Li et al. 3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor‐on‐a‐Chip
Peng et al. Challenges in bio-fabrication of organoid cultures
Du et al. Droplet array-based 3D coculture system for high-throughput tumor angiogenesis assay
Luo et al. Remote control of tissue interactions via engineered photo-switchable cell surfaces
Pradhan et al. Dual-phase, surface tension-based fabrication method for generation of tumor millibeads
Vikram Singh et al. Three‐dimensional patterning in biomedicine: Importance and applications in neuropharmacology
Wanigasekara et al. Advances in 3D culture systems for therapeutic discovery and development in brain cancer
US20160123960A1 (en) Method for preparing three-dimensional, organotypic cell cultures and uses thereof
Ayvaz et al. Three-dimensional cell culture models of hepatocellular carcinoma—A review
Khurana et al. Alginate-based three-dimensional in vitro tumor models: A better alternative to current two-dimensional cell culture models